A Unique Chimeric Antigen Receptor Directed Against ROR-1 Is Effective In-Vitro Against Multiple Tumor Cell Lines Regardless of Cell Of Origin. AKA I Am TAC, Hear Me ROR-1
Conferences
- Overview
- Research
- Additional Document Info
- View All
Overview
status
publication date
- March 1, 2019
has subject area
- 1103 Clinical Sciences (FoR)
- Pathology (Science Metrix)
published in
- Laboratory Investigation Journal